Relationship of serum imatinib trough level and response in CML patients: Long term follow-up-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Relationship of serum imatinib trough level and response in CML patients: Long term follow-up

Published:2010-12 Issue:12 Volume:34 Page:1573-1575
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Awidi Abdalla,Ayed Ayed O.,Bsoul Nazzal,Magablah Ahmad,Mefleh Razan,Dweiri Mohammad,Ramahi Mohammad,Arafat Eyad,Bishtawi Mohammad,Marie Lena

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference11 articles.

1. Imatinib pharmacokinetics and its correlation with response and safety in chronic phase chronic myeloid leukemia: a subanalysis of the IRIS study;Larson;Blood,2008

2. Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard dose imatinib in chronic myeloid leukemia;Picard;Blood,2007

3. Pharmacokinetic/pharmacodynamic correlation and blood-level testing in imatinib therapy for chronic myeloid leukemia;Cortes;Leukemia,2009

4. Impact of early dose intensity on cytogenetic and molecular responses in chronic-phase CML patients receiving 600mg/day of imatinib as initial therapy;Hughes;Blood,2008

5. Plasma or serum in therapeutic drug monitoring and clinical toxicology;Uges;Pharm World Sci,1988

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia;Pharmacology Research & Perspectives;2023-07-07

2. Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19;European Journal of Pharmaceutical Sciences;2023-05

3. Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience;Pharmacology Research & Perspectives;2022-09-14

4. External evaluation of population pharmacokinetic models of imatinib in adults diagnosed with chronic myeloid leukaemia;British Journal of Clinical Pharmacology;2021-11-26

5. Elevated acute phase proteins affect pharmacokinetics in COVID‐19 trials: Lessons from the CounterCOVID ‐ imatinib study;CPT: Pharmacometrics & Systems Pharmacology;2021-10-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3